ϳԹ

Skip to main content

Health + Wellness

eye1
Hero Type
Image
ϳԹ receives $1.5M grant from Foundation Fighting Blindness to test possible new treatment for inherited retinal disease
There’s only one U.S. Food and Drug Administration-approved therapy for an inherited retinal disease, and dozens of retinitis pigmentosa (RP) genes for which no therapy is available. With a new three-year, $1.5 million grant from the Foundation Fighting Blindness, Shigemi Matsuyama, an associate pr...
cancer-cells
Hero Type
Image
Unlocking the mystery of preexisting drug resistance: New study sheds light on cancer evolution
The evolution of resistance to diseases, from infectious illnesses to cancers, poses a formidable challenge. Despite the expectation that resistance-conferring mutations would dwindle in the absence of treatment due to a reduced growth rate, preexisting resistance is pervasive across diseases that ...
Untitled%20%2810%29_0.png
Hero Type
Image
Case Studies in Translational Science: Identifying Best Practices to Accelerate the Translational Process
In early 2024, the Clinical and Translational Science Award (CTSA) Coordination, Communication, and Operations Support (CCOS) Center awarded Working Group (WG) status to the “Translational Science Case Group”. This group, officially known as, "Learning about the Science of Translation: Identifying B...
Ashley Showers recognized as Certified Registered Nurse Anesthetist of the Year
The Ohio State Association of Nurse Anesthetist recently named Ashley Showers, assistant director of the Cleveland Clinic Foundation/Frances Payne Bolton Nurse Anesthesia Program, the Certified Registered Nurse Anesthetist of the Year. The award is given to a certified registered nurse anesthetist...
Undergraduate student selected for prestigious BioMed Amgen Scholars Program at Yale University
Reda Riffi, a first-generation student at ϳԹ, was selected to participate in the BioMed Amgen Scholars Program at Yale University this summer. Riffi is majoring in neuroscience and conducts research at ϳԹ in the Xiong Lab. The BioMed Amgen Scholars Program is a highly...
covid-19
Hero Type
Image
ϳԹ researcher, interdisciplinary team discover breakthrough on body’s adaptation to COVID-19
Since 2020, the COVID-19 pandemic has presented significant challenges to global public health, infecting millions and claiming numerous lives. While widespread vaccination efforts have alleviated the immediate threat, lingering questions persist about the long-term effects of the virus on those inf...
rachel-gardenhire-feat
Hero Type
Image
NFL chooses ϳԹ medical student for immersive experience with Cleveland Browns, University Hospitals to increase diversity in sports medicine
Rachel Gardenhire, a third-year medical student at ϳԹ, has been selected to take part in the 2024 NFL Diversity in Sports Medicine Pipeline Initiative, which aims to inspire medical students from various backgrounds to consider pursuing careers in sports medicine. Growi...
ai-cancer-mri-feat
Hero Type
Image
Researchers awarded $2.78M federal grant to improve rectal cancer treatment with artificial intelligence
With a new five-year, $2.78 million grant from the National Institutes of Health and National Cancer Institute, researchers at ϳԹ (ϳԹ), Cleveland Clinic and University Hospitals (UH) will use artificial intelligence (AI) to better treat rectal cancer patients. The Ame...
Two medicine staff members earn university awards
Exceptional staff members recognized for distinguished service and volunteerism ϳԹ staff members play a pivotal role in the university’s success, contributing to every aspect of campus life. Our employees are the backbone of the university—their dedication to areas from administra...
Mickel.jpg
Hero Type
Image
2024 Distinguished Alumnus Award
Andre K. Mickel, DDS, MSD, MDiv, DMin (DEN '91, DEN '94), a tenured full professor, will be honored with the 2024 Distinguished Alumnus Award. Dr. Mickel’s impact on education and research is undeniable. In 1995, Dr. Mickel was selected as the program director of the ϳԹ School of Dental Medicine ...